The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently diagnosed with Parkinson’s Disease ...

When we think of Parkinson's disease, we typically anticipate classic tremors, slow movement, and muscle stiffness. However, one component of Parkinson's disease that is rarely addressed is its impact ...

Adaptive deep brain stimulation has virtually eliminated the most debilitating motor symptoms for some Parkinson’s patients ...

Parkinsons is a chronic and progressive neurological condition that affects the nervous system and movement control Scroll ...

In January 2025 (U.S. time), the U.S. Food and Drug Administration (FDA) officially approved the Investigational New Drug (IND) application submitted by XellSmart Biopharmaceutical (Suzhou) Co., Ltd.

Brian Fiske, chief scientist at The Michael J. Fox Foundation for Parkinson’s Research, which funded some of Dr ...

JOINT BASE SAN ANTONIO-FORT SAM HOUSTON, Texas, April 11, 2025 – Two Air Force neurologists at Brooke Army Medical Center ...

A group in Laredo is giving hope to people living with Parkinson’s disease. The Parkinson’s Support Group is growing as more people come together to share their stories and learn from each other.

Idiopathic REM sleep behavior ... Clinical Trial Tests Novel Stem-Cell Treatment for Parkinson's Disease Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and ...

Over 90,000 people are diagnosed annually with disease. It impacts the nerve cells in the brain and causes tremors and other symptoms.

Members of the Our Place Parkinson’s support group learned about a newly approved therapy offering more consistent symptom ...

Friday marks World Parkinson's Day. It’s a disease nearly 90,000 Americans are diagnosed with each year, according to the ...